Industry analysts at PolicyLab put it plainly: evaluate providers on 12-month all-in cost at your maintenance dose, not the starter sticker
A ClinicalTrials.gov results posting usually follows within 12 months of primary-completion date
During the study period, there were 27 major adverse cardiovascular events, including heart attack and stroke, among people who received retatrutide, compared with 23 events in the placebo group
These include (in no particular order): Nausea Vomiting Diarrhea Constipation Stomach pain Loss of appetite Headache Dizziness Fatigue Injection site reactions (such as redness, swelling, or itching) Less common but more serious side effects of semaglutide may include: Pancreatitis (inflammation of the pancreas) Kidney problems Gallbladder problems Hypoglycemia (low blood sugar) Hypersensitivity reactions (such as rash, hives, or difficulty breathing) The majority of the side effects are short-lived and go away once your body gets used to the medication dosage
Concentration: 3.33 mg per mL 1 unit on a U-100 syringe = 0.0333 mg (33.3 mcg) Notice the 0.25 mg dose lands at 7.5 units
